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Abstract: Spices were some of the most valuable items of trade in the ancient and medieval world. Herbalist and folk 
practitioners have used plant remedies for centuries, but only recently have scientist begun to study the powers of com-
mon herbs and spices. In the current set-up, the anti-proliferative, anti-hypercholesterolemic, anti-diabetic, anti-
inflammatory effects of spices have overriding importance, as the key health concern of mankind nowadays is diabetes, 
cardio-vascular diseases, arthritis and cancer. Spices or their active compounds could be used as possible ameliorative or 
preventive agents for these health disorders. Spices are rich in antioxidants, and scientific studies suggest that they are also 
potent inhibitors of tissue damage and inflammation caused by high levels of blood sugar and circulating lipids. Because 
spices have very low calorie content and are relatively inexpensive, they are reliable sources of antioxidants and other po-
tential bioactive compounds in diet. This review outlines the role of some spices used in the Indian kitchen for its flavour 
and taste which are potential to maintain a healthy heart. 
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INTRODUCTION 
  Currently there has been an augmented interest globally 
to identify compounds isolated from natural products that are 
pharmacologically effective and have low or no side effects 
for use in preventive medicine and the food industry. Alex-
ander the Great's campaigns in Central Asia around 330 B.C. 
are often credited for the dissemination and adoption of 
herbs and spices among many cultures because they intro-
duced Asian, Persian, Indian, and Greek cultures and ideas 
[1, 2]. Early records indicate that herbs and spices were used 
as medicines in ancient Egypt and Asia and as food preserva-
tives in ancient Rome and Greece [3]. Herbs and spices con-
tinued to be used during the middle ages for flavoring, food 
preservation, and/or medicinal purposes [4]. In countries like 
India where poverty and malnutrition is unbridled, knowl-
edge of plant derived antioxidants and spices could reduce 
the cost of health care. India has a rich history of using vari-
ous herbs, spices and herbal components for treating various 
diseases [5]. It has been believed for some time that dietary 
factors play a key role in the development of some human 
diseases, including cardiovascular disease. Several herbs and 
spices of culinary origin were included in the “approved” 
monographs, such as caraway oil and seed, cardamom seed, 
cinnamon bark, cloves, coriander seed, dill seed, fennel oil 
and seed, garlic, ginger root, licorice root, mint oil, onion, 
paprika, parsley herb and root, peppermint leaf and oil, 
rosemary, sage, thyme, turmeric root, and white mustard 
seed [6]. The use of herbal medicine has skyrocketed over 
the last 10 years, with out-of-pocket costs estimated at more 
than $5 billion in the United States alone. The following 
review of herbal medicines affecting the cardiovascular sys-
tem is based on information gleaned from the scientific lit-  
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erature. Most herbal medicinals have multiple effects modu-
lating the cardiovascular system [7]. In the traditional Indian 
system of medicine Ayurveda and Siddha various spices and 
herbs are described to possess medicinal properties, such as 
being antithrombotic,  antiatherosclerotic, hypolipidemic, 
hypoglycemic, anti-inflammatory, antiarthritic, etc [8]. 
  Spices were some of the most valuable items of trade in 
the ancient and medieval world. Herbalist and folk practitio-
ners have used plant remedies for centuries, but only recently 
have scientist begun to study the powers of common herbs 
and spices. Spices are rich in antioxidants, and a scientific 
study suggests they are also potent inhibitors of tissue dam-
age and inflammation caused by high levels of blood sugar 
and circulating lipids. Due to their phenol content these are 
able to block the formation of compounds that contribute to 
damage caused by metabolic disorders. Because spices have 
very low calorie content and are relatively inexpensive, they 
are reliable sources of antioxidants and other potential bioac-
tive compounds in diet [9]. The major focus of this review is 
on the role that spices play an inevitable role in the manage-
ment of heart diseases, serving as agents both for prevention 
and treatment. Overall the review suggests "adding spice to 
our life" may serve as a delicious and sensible way to main-
tain a healthy heart. 
GARLIC 
  Several epidemiologic studies have indicated that certain 
diets are associated with low risk of cardiovascular disease 
and that these diets are rich in fruits, herbs and spices; the 
common spice among them is garlic [10].Garlic (Allium sati-
vum) is believed to have originated in Central Asia and be-
longs to the Alliacae family. It is used universally as a fla-
voring agent, traditional medicine, and a functional food to 
enhance physical and mental health. Over the centuries, gar-
lic has acquired a unique position in the myths of many cul-
tures as an appalling prophylactic and therapeutic medicinal Spices for Healthy Heart  Current Cardiology Reviews, 2010, Vol. 6, No. 4    275 
agent. It has been quoted in the Egyptian Codex Ebers, a 35-
century-old document, as useful in the treatment of heart 
disorders, tumors, worms, bites and other ailments. Hippo-
crates and Pliny the Elder were both promoters of the intrin-
sic worth of garlic [11]. The first-century Indian physician 
Charaka (3000 BC), the father of Ayurvedic medicine, 
claimed that garlic acts as a heart tonic by maintaining the 
fluidity of blood and strengthens the heart [12]. Over the last 
20 years, this important and exciting role of garlic has been 
and continues to be confirmed by basic and clinical research 
reports from around the world. 
  Garlic has been advocated for the prevention of heart 
disease [13]. Epidemiologic studies show an inverse correla-
tion between garlic consumption and progression of cardio-
vascular disease. Cardiovascular disease is associated with 
multiple factors such as raised serum total cholesterol, raised 
LDL and an increase in LDL oxidation, increased platelet 
aggregation, hypertension, and smoking [14]. Garlic has 
been shown to inhibit enzymes involved in lipid synthesis, 
decrease platelet aggregation, prevent lipid peroxidation of 
oxidized erythrocytes and LDL, increase antioxidant status, 
and inhibit angiotension-converting enzyme [11].  Allicin, 
an active compound of garlic showed significantly lowered 
formation of fatty streaks in the aortic sinus [15]. Kleijnen 
et al. [16] showed that it also enhance blood fibrinolytic ac-
tivity. Another in-vitro study shows that water – soluble or-
ganosulphur compound S –allyl cysteine present in aged 
garlic extract is a potent inhibitor of cholesterol synthesis 
[17, 18]. These findings have also been addressed in clinical 
trials too. The studies point to the fact that garlic reduces 
cholesterol, inhibits platelet aggregation, reduces blood pres-
sure, and increases antioxidant status [14]. There is level III-
3 evidence (National Health and Medical Research Council 
[NHMRC] levels of evidence) that consuming a half to one 
clove of garlic (or equivalent) daily may have a cholesterol-
lowering effect of up to 9%. There is level III-1 evidence 
that 7.2 gm of aged garlic extract has been associated with 
anticlotting (in-vivo studies), as well as modest reductions in 
blood pressure (an approximate 5.5% decrease in systolic 
blood pressure) [19]. Warshafsky et al. [20] showed that an 
average of 900 mg garlic/ day could decrease total serum 
cholesterol levels by approximately 9%. Its consumption has 
been shown to have antiatherosclerotic activity to increase 
high-density lipoprotein (HDL) levels, which may help to 
remove excess cholesterol from arterial tissue in animal 
models and human cell cultures. It has been reported to have 
lipid-and blood pressure-lowering action, as well as anti-
platelet, antioxidant, and fibrinolytic effects [21]. Garlic 
educes nitric-oxide-dependent relaxation in pulmonary arter-
ies [22, 23]. Recently, Subhendhu et al. [24] have observed 
that freshly crushed garlic exerts superior cardioprotective 
activity than processed garlic. Their results show that freshly 
crushed garlic fed rats displayed significantly greater phos-
phorylation of antiapoptotic ERK1/2 proteins, reduced 
Bax/Bcl-2 ratio, and reduced phosphorylation of proapop-
totic p-38MAPK and JNK. It enhanced redox signaling by 
increasing p65 subunit of NFB, Nrf2, and enhanced GLUT 
4, PPAR, and PPAR. Also the survival signaling network 
consisting of Akt-FoxO1 was increased in the freshly 
crushed garlic treated hearts. Thus, to conclude it could be 
stated that garlic has multiple properties in the prevention of 
cardiovascular diseases and has to be taken as dietary sup-
plement for prevention of CVD. 
CURCUMIN 
  Curcumin is an inevitable spice as well medicine used in 
the ancient traditional medicinal systems like Siddha and 
Ayurveda whose history goes back to over 5000 years. In 
Indian and Chinese medicines, turmeric was used as an anti-
inflammatory agent to treat gas, colic, toothaches, chest 
pains, and menstrual difficulties. This spice was also used to 
help with stomach and liver problems, to heal wounds and 
lighten scars, and as a cosmetic [25]. In a natural mutant 
model of obesity, turmeric (at 1 and 5% of the diet) had sig-
nificantly reduced cholesterol and triglyceride concentrations 
while increasing HDL cholesterol, within 4 weeks. Further 
evidence indicates that it reduces the oxidation of LDL, 
blood glucose and renal lesions in diabetes. In addition, it 
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has been demonstrated to reduce platelet aggregation, cy-
clooxegenase, thromboxane, smooth muscle cell prolifera-
tion and endothelial dysfunction. Both turmeric and curcu-
min, due to their antioxidant and anti-inflammatory activity, 
have been demonstrated to counteract several disorders such 
as myocardial infarctions, chronic inflammatory lung dis-
eases, pancreatitis, inflammatory bowel diseases, neurode-
generative diseases, hepatic and lung damages as well as 
muscle injuries and cystic fibrosis [26] Curcumin can also 
impact on the process of cataractogenesis and delays galac-
tose-induced cataracts formation in rats [27]. 
  Studies show that the preventive mechanisms of curcu-
min regarding with heart disease is multi targeted. The anti-
oxidant effects of curcumin have been shown to attenuate 
adriamycin-induced cardiotoxicity [28] and may prevent 
diabetic cardiovascular complications [29] antithrombotic, 
[30] anti-proliferative, [31] and anti-inflammatory effects of 
curcumin and the effect of curcumin in decreasing the serum 
cholesterol level may protect against the pathological 
changes seen in atherosclerosis [32].  Curcumin, present in 
turmeric inhibits NF-B transcriptional factor, through inhi-
bition of IKK, a kinase which is needed for NF-kB activa-
tion; improve the surge of pro-inflammatory cytokines dur-
ing cardiopulmonary bypass (CBP) and decreases cardio-
myocytic apoptosis after global cardiac ischemia/reperfusion 
injury [33]. More extensive research regarding the effect of 
curcumin on the cardiovascular diseases in both humans as 
well as in animals is defensible. 
GINGER 
 Ginger  (Zingiber officinale Roscoe, Zingiberacae) is a 
medicinal plant that has been widely used in Chinese, 
Ayurvedic and Tibb-Unani herbal medicines all over the 
world, since ancient times, for a wide range of unrelated ail-
ments that include arthritis, rheumatism, sprains, muscular 
aches, pains, sore throats, cramps, constipation, indigestion, 
vomiting, hypertension, dementia, fever, infectious diseases 
and helminthiasis [34]. The health benefits of ginger docu-
mented over 2,000 years ago indicates that ginger has vari-
ous medicinal properties. The active ingredient in ginger is 
gingerol, a compound that's thought to relax blood vessels, 
stimulate blood flow and relieve pain. Other potentially ac-
tive compounds present in ginger are phenolic compounds – 
shogaols and gingerols; sesquiterpenes - bisapolene, 
zingiberene, zingiberol, sesquiphellandrene, curcurmene and 
other compounds are 6-dehydrogingerdione, galanolactone, 
gingesulfonic acid, zingerone, geraniol, neral, monoacyldiga-
lactosylglycerols, gingerglycolipids [35]. 
  Ginger is also an anti-inflammatory agent, which means 
it may be useful in fighting heart disease, cancer, Alz-
heimer's disease and arthritis. Antimicrobial, anti thrombotic, 
anti-inflammatory and anticancer  activity have also been 
reported [36]. 
  In a placebo controlled clinical trial patients administered 
with single dose of 10 g powdered ginger administered to 
Coronary artery diseased patients produced a significant re-
duction in platelet aggregation induced by the two agonists, 
but did not affect the blood lipids and blood sugar [37]. Hy-
perlipidemic rabbits when challenged with a 50% ethanolic 
extract of ginger showed a reduction in total cholesterol and 
serum LDL-cholesterol. A reduction in HDL ratio was seen 
in atherofed rabbits compared with controls which were re-
stored when challenged with the Zingiber extract. An athero-
genic index of 4.7 was brought down to 1.2 using plant 
products. The tissue lipid profiles of liver, heart and aorta 
showed similar changes to those noticed in serum lipids 
[38]. Zingiber extract feeding in diabetic rats increased the 
fecal excretion of cholesterol thus suggesting a modulation 
of absorption.  Ethanolic extract of  ginger can protect the 
tissues from lipid peroxidation. The extract also exhibit sig-
nificant lipid lowering activity in diabetic rats [39]. 
  Consumption of ginger extract inhibited the progression 
of aortic atherosclerosis in atherosclerotic, apolipoprotein- E 
deficient mice. This effect was associated with a significant 
reduction in the plasma and LDL cholesterol levels, with a 
parallel reduction in the oxidative response of macrophages, 
and reduced LDL atherogenic modifications (oxidation and 
aggregation). The anti-atherogenicity of ginger extract could 
also be attributed to its direct antioxidative effects on macro-
phages as well as on plasma LDL [40]. Guh et al. [41] 
showed that Gingerol isolated from Zingiber inhibit platelet 
function by inhibiting thromboxane formation. Feeding rats 
with ginger significantly elevated the activity of hepatic cho-
lesterol-7-hydroxylase, the rate-limiting enzyme in bile 
acids biosynthesis, thereby stimulating cholesterol conver-
sion to bile acids, resulting in elimination of cholesterol from 
the body [42]. In addition, a pure constituent from ginger [E-
8 beta, 17 epoxylabd-12-ene-15, 16-dial (ZT)], was shown to 
inhibit cholesterol biosynthesis in homogenated rat liver 
[43]. In 20 healthy young male volunteers, ginger supple-
mentation (5gms daily) significantly inhibited the platelet 
aggregation induced by ADP (adenosine diphosphate) and 
epinephrine [44]. In human volunteers who took a huge (10 
gram) one-time dose of dried ginger, there was a marked 
inhibition of platelet aggregability [37]. Another study 
showed no significant impact of fresh or cooked ginger 
(doses up to 15 grams of fresh ginger or 40 grams of cooked 
ginger) on thrombotic activity or platelet thromboxane pro-
duction [45]. The above mentioned reports evidence the car-
dioprotective potential of ginger and thus could be used for 
the prevention and treatment of cardiovascular disorders by 
adding them in our day to day dietary intake. 
BLACK PEPPER 
  Pepper is an extensively used spice both in Eastern and 
Western food. It has an impressive antioxidant and antibacte-
rial effect and helps with digestion and weight loss because it 
stimulates the breakdown of fat cells. Black pepper is con-
sidered as the king of spices, as it fetches the highest return 
as judged from the volume of international trade. Black pep-
per or its active principle piperine has been experimentally 
demonstrated by a number of independent investigators to 
possess diverse physiological effects. Piperine has been 
demonstrated in in vitro studies to protect against oxidative 
damage by inhibiting or quenching free radicals and reactive 
oxygen species. Black pepper or piperine treatment has also 
been evidenced to lower lipid peroxidation in vivo and bene-
ficially influence cellular thiol status, antioxidant molecules 
and antioxidant enzymes in a number of experimental situa-
tions of oxidative stress [46]. Wakade et al. showed that the 
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protection against adriamycin induced cardiotoxicity by vir-
tue of its antioxidant and free radical scavenging capacity. 
Black pepper has been reported to influence lipid metabo-
lism predominantly by mobilization of fatty acids [47]. An in 
vivo study on hypolipidemic effect of black pepper (Piper 
nigrum Linn.) in high fat diet fed rats treated with black pep-
per as well as piperine showed remarked decrease in the lev-
els of cholesterol (both the free and ester cholesterol frac-
tions), free fatty acids, phospholipids and triglycerides. 
Moreover, supplementation of the high fat fed rats with 
black pepper elevated the concentration of high density lipo-
protein-cholesterol (HDL-c) and reduced the concentrations 
of low density lipoprotein-cholesterol (LDL-c) and very low 
density lipoprotein-cholesterol (VLDL-c) in the plasma as 
compared with the levels in unsupplemented high fat fed rats 
[48]. Vanadium compounds also promote cardiac function 
by activating Akt signaling through inhibition of protein ty-
rosine phosphatases. Black pepper, being rich in containing 
vanadium in it thus elicits cardiac functional recovery in 
myocardial infarction and pressure overload–induced hyper-
trophy [49]. 
CINNAMON 
 Cinnamon  belongs to genus Cinnamomum, family Laura-
ceae  which is distributed in India, Egypt, China, Srilanka 
and Australia. Cinnamon  leaves and bark are used exten-
sively as spices in food or to produce essential oils [50]. 
Studies have shown the antioxidant and antimicrobial poten-
tial [51], the antidiarrhoeal activity of Cinnamon is also well 
documented. The ‘Indian Materia Medica’ [52] and the ‘In-
dian Medicinal Plants – A Compendium of 500 species’ [53] 
classifies cinnamon as a herbal drug which has cardiovascu-
lar effects. Wang et al. [54] in their study using guinea pig 
heart showed that a decoction of cinnamon increased coro-
nary blood flow and provoked pituitrin induced reduction of 
blood flow. Also it reduced peripheral vascular resistance, 
suggesting an undeviating vasodilation of peripheral vessels. 
Increased cardiac contractile force and beating rate was also 
exerted by cinnamaldehyde, which is present in cinnamon. 
Circulatory stimulant effects of cinnamon have been reported 
in several books on medicinal plants and also in Ayurveda 
[55, 56]. Dietary cinnamon increases bilary secretion of cho-
lesterol and phospholipids without affecting the bile content 
(Sambaiah and Sreenivasan [42]. Sharma et al. [57] studied 
the effect of a 50% alcoholic extract of cinnamon on rats and 
reported a significant anti-hypercholesterolemic action and 
reduced serum triglyceride level at a single dose of 250 
mg/kg body weight. Suppression of total serum cholesterol, 
triglycerides, phospholipids and low density lipoprotein lev-
els was observed in another investigation using triton WR-
1339-induced hyperlipidaemic rats [58]. The same group in 
their extension study with 80% methanolic extract and its 
chloroform fraction of different species of Cinnamomum 
observed that the extracts suppressed the elevated serum 
total cholesterol and triglyceride levels in corn oil-induced 
hyperlipidaemic rats. The chloroform fraction exhibited re-
markable inhibitory effects on HMG-CoA reductase, an en-
zyme that catalyses cholesterol biosynthesis. Kamal [59]   
et al. showed in their study that cinnamon extract improved 
lipid profile by extensively decreasing total cholesterol, 
triglycerides and LDL – C levels with increasing serum HDL 
– C. It also hampers HMG-CoA reductase activity in liver 
thereby lowering the Cholesterol levels. Cinnamon activates 
PPAR resulting in improved insulin resistance and reduced 
fasted LDL-c, thereby managing obesity related hyperlipi-
demia and also increases NO levels, which is 
a potent Vasodilator.  Cinnamon demonstrated significant 
ability to inhibit initiation as well as propagation of lipid 
peroxidation due to their polyphenol content, strong reducing 
power and superoxide radical scavenging activity [60]. Cin-
namon exhibited linear dose-dependent Nitric oxide sup-
pressing effect without any effect upon cell viability [8]. 
Peroxisome proliferator-activated receptors (PPARs  and ), 
one among the transcriptional factors involved in the regula-
tion of insulin resistance and adipogenesis is found to get 
activated, resulting in improved insulin resistance, reduced 
fasted glucose, FFA, LDL-c, and AST levels in high-caloric 
diet-induced obesity (DIO) and db/db mice fed with cinna-
mon water extract [61]. 
CORIANDER 
  Coriandrum sativum (Coriander) has been documented as 
a traditional treatment for cholesterol and diabetes patients. It 
has a long history as a traditional medicine [62]. The seeds 
of coriander have a remarkable hypolipidemic action. The 
levels of total cholesterol and triglycerides decreased signifi-
cantly in the tissues of the animals of the experimental group 
which received coriander seeds. Significant increases in -
hydroxy, -methyl glutaryl CoA reductase and plasma lecithin 
cholesterol acyl transferase activity were noted in the ex-
perimental group. The level of LDL + VLDL cholesterol 
decreased while that of HDL cholesterol increased in the 
experimental group compared to the control group. The in-
creased activity of plasma LCAT enhanced hepatic bile acid 
synthesis and the increased degradation of cholesterol to 
fecal bile acids and neutral sterols appeared to account for its 
hypocholesterolemic effect [63]. Thrombosis, an important 
event in cardiovascular diseases, can be fatal if platelet ag-
gregation takes place in the narrowed lumen of arteries, 
causing an impairment of blood flow to the heart. Attempts 
have been made to study the antiplatelet activity of leaf spice 
extracts, as these are rich sources of natural antioxidants. 
Aqueous extracts of coriander leaf and curry leaf were tested 
on human platelets over a wide range of concentrations. Both 
these leaf spice extracts inhibited human platelet aggregation 
[64]. Another in vivo study shows that there is a remarkable 
decrease in the levels of TC, TG, TAG and LDL-c in plasma, 
also there was a significant increase in the levels of HDL-c 
observed in the cholesterol-rich (1%) basal diet fed rats 
treated with coriander seed oil [65]. 
CONCLUSION 
  To summarize, spices are heterogeneous collections of a 
wide variety of volatile and non-volatile staple dietary addi-
tives. India with its wide climatic conditions and topographi-
cal features naturally possesses wide variety of spices which 
are being used in the diet. The above discussed spices 
namely garlic, pepper, coriander, ginger, turmeric, cinnamon 
are commonly used spices in Indian delicacies. These spices 
turn an ordinary meal to an extraordinary experience. They 
have a diverse array of natural phytochemicals that have 
complementary and overlapping actions. As several meta-278    Current Cardiology Reviews, 2010, Vol. 6, No. 4  Vasanthi and Parameswari 
bolic diseases and age-related degenerative disorders such as 
cardiovascular disorders are closely associated with oxida-
tive processes in the body, the use of herbs and spices as a 
source of antioxidants to combat oxidation warrants further 
attention. From a dietary perspective, the functionality of 
herbs and spices will be exposed through consideration of 
their properties as foods. As with most foods, the real bene-
fits of including them in the diet are likely to emerge with a 
better understanding of the attributes of health that are best 
supported by food, and in methodological developments ad-
dressing the evidence base for their effects. These develop-
ments are well underway through evidence-based frame-
works for substantiating health claims related to foods for a 
healthy heart. At present, recommendations are warranted to 
support the consumption of foods rich in bioactive compo-
nents, such spices. With time, we can expect to see a greater 
body of scientific evidence supporting the benefits of spices 
in the overall maintenance of a healthy heart which is the 
most important organ for every beat of life and protection 
from diseases of the heart. 
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